Serge Langford
Director/Board Member at Aegera Therapeutics, Inc.
Network origin in Serge Langford first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
11
| Subsidiary | Biotechnology | 11 |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada.
9
| Holding Company | Pharmaceuticals: Major | 9 |
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Serge Langford via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Director/Board Member Chairman | |
| PALADIN LABS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| GELESIS INC | Biotechnology | Director/Board Member | |
| APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
BDO Dunwoody LLP
 BDO Dunwoody LLP Miscellaneous Commercial ServicesCommercial Services Part of BDO LLP, BDO Dunwoody LLP is a Canadian company that provides accounting services. The company is based in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| McGill University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
BDC Venture Capital
 BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Private Equity Investor Private Equity Investor | |
| YPSOMED HOLDING AG | Medical Specialties | Director/Board Member | |
| University of Toronto | College/University | Masters Business Admin Doctorate Degree | |
| McMaster University | College/University | Masters Business Admin Doctorate Degree | |
| University of Montréal | College/University | Doctorate Degree Doctorate Degree | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer | |
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investment Managers | Private Equity Investor Private Equity Investor | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Université Libre de Bruxelles | College/University | Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| BANGI INC. | Biotechnology | Director/Board Member | |
| SQI DIAGNOSTICS INC. | Medical Specialties | Director of Finance/CFO | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Canadian Tax Foundation | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
AgeChem Financial, Inc.
 AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Sir George Williams University | College/University | Masters Business Admin | |
Ypsomed AG
 Ypsomed AG Medical SpecialtiesHealth Technology Part of Ypsomed Holding AG, Ypsomed AG is a Swiss company that manufactures injection and infusion systems for self-medication and renowned diabetes. The company is based in Burgdorf, Switzerland. | Medical Specialties | Director/Board Member | |
Les Équipements Power Survey Ltée
 Les Équipements Power Survey Ltée Alternative Power GenerationUtilities Power Survey & Equipment Ltd. provides solutions for measuring and analyzing the intensity of harmonic currents and voltages. Its products include capacitor banks, harmonic filters, accessories and distribution. The firm offers power factor correction, harmonic distortion correction, start-up and commissioning, preventive maintenance, and technical training services for commercial and institutional, industrial and manufacturing, mining, metal and mineral, oil and gas, grid and transportation industries. The company was founded by 1948 and is headquartered in Montreal, Canada. | Alternative Power Generation | Director of Finance/CFO | |
| AMYLYX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| COVETRUS, INC. | Packaged Software | Director/Board Member | |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| CANNARA BIOTECH INC. | Agricultural Commodities/Milling | Director of Finance/CFO | |
| Group JS International Ltd. | Director of Finance/CFO | ||
| Jouveinal Canada | Chief Executive Officer | ||
DalCor Pharma UK Ltd.
 DalCor Pharma UK Ltd. BiotechnologyHealth Technology Founded in 2015, DalCor Pharma UK Ltd. is a subsidiary of DalCor Pharmaceuticals Canada, Inc. The company is based in Leatherhead, UK. The British company engages in research and experimental development on biotechnology. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Allyx Therapeutics, Inc.
 Allyx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Allyx Therapeutics is an American clinical-stage biotechnology company founded in 2019 by a group of experienced biopharma industry executives, venture capitalists, and scientific experts. The company is based in an undisclosed location and aims to deliver a novel approach to preserve and protect synapses for people living with neurodegenerative diseases. Its lead compound, alx-001, is a first-in-class oral therapy with a unique mechanism of action at mglur5 currently in clinical development in Alzheimer's disease. The company is developing an oral drug that demonstrates reversal of learning and memory deficits due to Alzheimer's disease. The company was founded by Timothy Siegert, Stephen M. Bloch, Paul R. Fonteyne, and Stephen M. Bloch has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
Revelar Biotherapeutics, Inc.
 Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Revelar Biotherapeutics is a biopharmaceutical company based in Bethesda, MD. Revelar Biotherapeutics, Inc. focuses on developing and commercializing breakthrough therapeutic antibody products to address critical unmet patient needs, particularly in the field of COVID-19 and other therapeutic areas. The company's management team has extensive expertise in clinical development, regulatory affairs, business development, and operations with leading pharmaceutical companies. Revelar was spun out of Twist Bioscience in November 2021 and has the ability to leverage Twist Biopharma's antibody discovery and optimization platform to license additional antibodies for non-COVID targets. The company's therapeutic areas of interest include oncology and infectious diseases. Revelar aims to combine its clinical development and commercialization capabilities with Twist's innovative technology platform and industry and academia collaborations to accelerate the discovery and delivery of transformative antibody therapeutics to meet patients' unmet needs. Revelar was founded by Kevin P. Malobisky, and the CEO is Glenn Marina. | Biotechnology | Director/Board Member | |
| GELESIS HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
| Thyron Pharmaceuticals, Inc. | Chief Executive Officer | ||
St. Bernard Soap Co.
 St. Bernard Soap Co. Household/Personal CareConsumer Non-Durables Part of Trillium Health Care Products, Inc., St. Bernard Soap Co. is a company that manufactures and sells bar soaps. The company is based in Cincinnati, OH. | Household/Personal Care | Chairman |
Statistics
International
| Canada | 25 |
| United States | 22 |
| Switzerland | 3 |
| Germany | 2 |
| Belgium | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Finance | 5 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 126 |
| Corporate Officer/Principal | 36 |
| Chairman | 23 |
| Independent Dir/Board Member | 23 |
| Chief Executive Officer | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Louis P. Lacasse | 26 |
| Paul R. Fonteyne | 25 |
| Robert McNeil | 21 |
| Joe Regan | 17 |
| Michael B. Cross | 15 |
| Graham Eric Fagg | 14 |
| Lennie Ryer | 12 |
| Perry B. Molinoff | 12 |
| John W. Gillard | 12 |
| Royston Glasspool | 11 |
| Yvon Bastien | 11 |
| Inès Holzbaur | 11 |
| Laurence Rulleau | 9 |
| Nick Photiades | 9 |
| Fouzia Laghrissi-Thodes | 8 |
- Stock Market
- Insiders
- Serge Langford
- Company connections
